For patients with diabetes, ticagrelor reduced heart attacks, strokes

A clinical trial evaluated whether adding ticagrelor to aspirin improves outcomes for patients with stable coronary artery disease and diabetes mellitus but without a history of heart attack or stroke. Researchers found that taking ticagrelor in addition to aspirin reduced the risk of a composite of cardiovascular death, heart attack, or stroke.